Tag: FDA approval
New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy
The U.S. Food and Drug Administration (FDA) recently approved a new drug called Jemperli (dostarlimab-gxly) for certain adult patients with endometrial cancer. This drug, developed by British pharmaceutical company GSK, is designed for individuals...
Blood-Based Concussion Test Approved by FDA: Potential Interest from NHL
Brad Marchand, the Boston Bruins captain, suffered a concussion during a playoff game after colliding with an opponent. Despite showing signs of a head injury, Marchand continued to play until the medical staff pulled...
New FDA-Approved Drug for Autoimmune Liver Disease: A Breakthrough Treatment
A breakthrough treatment for autoimmune liver disease has been approved by the U.S. Food and Drug Administration (FDA). The medication, Iqirvo (elafibranor), developed by French drugmaker Ipsen, is a new 80 mg tablet that...
New Title: FDA Advisory Panel Approves Experimental Alzheimer’s Drug: Promising Progress Ahead
An experimental Alzheimer’s drug called donanemab received approval from a U.S. Food and Drug Administration advisory panel. The drug is intended to treat early symptoms of Alzheimer’s disease, such as mild cognitive impairment and...
Expert Panel Backs FDA Approval of New Alzheimer’s Drug
An expert panel recently gave its support for the FDA approval of a new drug for Alzheimer's disease called donanemab, manufactured by Eli Lilly. The panel, made up of independent advisors to the FDA,...
Experimental Alzheimer’s drug receives FDA advisory panel’s approval: Progress is happeningSEO-friendly title: Alzheimer’s Drug...
An experimental Alzheimer's drug called donanemab received an endorsement from a U.S. Food and Drug Administration (FDA) advisory panel. The drug is intended to target symptoms of early Alzheimer's disease, such as mild cognitive...
Expert Panel Endorses FDA Approval of New Alzheimer’s Drug New Alzheimer’s Drug Receives Expert Panel...
An expert panel has given their endorsement to the FDA approval of a new drug for Alzheimer's disease. The drug, called donanemab and manufactured by Eli Lilly, was found to have modest benefits that...